Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in Recurrent Pituitary Tumors
NCT00939523Phase 2Completed
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Jul 2009
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in pituitary adenoma, prolactinoma, Cushing's disease (CD), Pituitary carcinoma (PC), sponsored by Cedars-Sinai Medical Center. Started Jul 2009; status: completed.
02
Drugs
lapatinib
03
Conditions
pituitary adenomaprolactinomaCushing's disease (CD)Pituitary carcinoma (PC)
Beyond the preview
Go deeper on NCT00939523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00939523.